Tzu Chi University

In this double-blind randomised controlled trial of 58 patients with 58 diabetic foot ulcers, a topical probiotic formulation in soybean concentrate significantly accelerated wound healing compared with placebo. The mean time to complete healing was 89.6 vs. 165.9 days (P = 0.012), with higher healing rates from week 20 onwards. The treatment was safe and well tolerated, supporting topical probiotics as a promising adjunctive therapy for chronic diabetic foot ulcers.

A BSTRACT Objectives: Vegan diet – the exclusion of all animal products, even eggs and dairy – ranked the most climate-friendly diet, but concerns persist regarding its nutritional adequacy, particularly for omega-3 fatty acids, vitamin D, and iodine. This study compares the nutritional status of fatty acids, vitamin D, and iodine, among Taiwanese vegans, vegetarians, and omnivores. Materials and Methods: This cross-sectional study included 45 omnivores, 46 lacto-ovo vegetarians, and 24 vegans. Blood and urine samples were collected to analyze nutritional biomarkers, including erythrocyte fatty acid profiles, plasma vitamin D, and urinary iodine. Results: Vegans had the lowest median percentage of saturated fatty acids, trans-fatty acids, and omega-3 fatty acids, including EPA and DHA, but the highest levels of omega-6 fatty acids. The medians (P25–P75) of omega-3 index values were 2.6 (2.4–2.8), 3.7 (3.2–4.5), and 5.8 (5.0–6.5) for vegans, vegetarians, and omnivores, respectively. Vitamin D deficiency was most prevalent among vegans (75%), followed by omnivores (36%) and vegetarians (24%). Iodine insufficiency was also more common in vegans (76%) than in vegetarians (57%) and omnivores (56%). Conclusion: Taiwanese vegan diets may be advantageous in lowering saturated fatty acids and trans-fatty acid status but may be associated with a higher risk of deficiency for omega-3 fatty acids, vitamin D, and iodine. Strategies to enhance the adequacy of these nutrients may be needed to improve the quality of vegan diets.

Prostate cancer (PCa) is the most general cancer in men and is often linked with distant metastasis in its later stages. The caffeic acid (CA) derivative, N-(4-methoxyphenyl)methylcaffeamide (MPMCA), demonstrates superior liver-protective effects compared to CA. Nevertheless, the functions of MPMCA on prostate cancer metastasis remain unclear. Here, we demonstrate that MPMCA blocks migration and invasion in prostate cancer cells without affecting cell viability. By suppressing the production of mesenchymal markers Vimentin, N-cadherin and β-catenin and upregulating the production of the epithelial marker Zonula Occludens-1 (ZO-1), MPMCA also controls Epithelial-Mesenchymal Transition (EMT). The Phosphoinositide 3-kinase (PI3K), Protein kinase B (AKT) and mechanistic target of rapamycin (mTOR) pathway has been documented to regulate MPMCA-inhibited cell motility. Transfection with Snail and Slug cDNA reverses MPMCA's suppression of EMT, migration, and invasion in prostate cancer cells. Importantly, our in vivo data indicates that MPMCA reduces Snail and Slug expression and prostate cancer metastasis. Our evidence suggests that MPMCA is a novel therapeutic candidate for treating metastatic prostate cancer.

A nucleotide substitution in codon 97 of HLA-B*40:337:01N results in a novel null allele, HLA-B*40:337:02N.

Background: This study investigated the association between tongue strength, measured using the Iowa Oral Performance Instrument (IOPI), and upper airway collapse patterns observed during drug-induced sleep endoscopy (DISE) in patients with obstructive sleep apnea syndrome (OSAS). Methods: Thirty patients who underwent polysomnography, DISE, and tongue pressure measurement were retrospectively analyzed. Upper airway collapse was assessed using the VOTE classification. The tongue strength task performed using the IOPI requires participants to compress an air-filled bulb placed on the hard palate with anterior tongue to generate maximum isometric tongue pressure. Group comparisons and ordinal logistic regression with Firth's penalized likelihood were performed to evaluate associations between tongue pressure and collapse patterns. Results: The participants had a mean age of 41.5 ± 12.5 years, including 27 males and 3 females. The mean tongue strength was 50.4 ± 15.3 kPa, with no significant sex-related differences. Patients with tongue strength <40 kPa showed significantly higher odds of tongue base collapse (adjusted OR 12.79, 95% CI 1.30-126.91) and epiglottic collapse (adjusted OR 54.05, 95% CI 1.66-1760.25). No significant differences were observed for velum or oropharyngeal collapse. Conclusions: Lower tongue strength was associated with increased likelihood of tongue base collapse during DISE. Tongue strength measurement may serve as a practical, non-invasive tool for identifying patients with reduced tongue muscle function and potential tongue-related airway obstruction.

To evaluate the prognostic values of 18F-FDG PET-derived whole-body imaging features in patients with metastatic lung adenocarcinoma treated with EGFR-targeted therapies. We retrospectively analyzed 249 patients with lung adenocarcinoma who underwent pre-treatment 18F-FDG PET and were treated with EGFR-targeted agents. The patients were divided into analog (n = 150) and digital (n = 99) PET cohorts. Whole-body and primary tumor respiratory-stable imaging features were extracted. The prognostic values of the study variables for progression-free (PFS) and overall survival (OS) were assessed using univariate and multivariate Cox regression analyses across the analog and digital PET cohorts. Total sphericity and primary tumor inverse difference normalized were independent predictors of both PFS and OS. The total metabolic tumor volume was another independent predictor of OS. Combined models integrating these imaging biomarkers with clinical variables outperformed the traditional staging system (c-indices for PFS: 0.649 versus 0.550 for analog and 0.668 versus 0.583 for digital PET cohorts; for OS: 0.694 versus 0.562 for analog and 0.728 versus 0.579 for digital PET cohorts). Our models showed consistent predictive values across subgroups based on sex, EGFR mutation subtype, and clinical stage. Our results indicate that models integrating whole-body 18F-FDG PET features with traditional variables can enhance survival prediction and may support personalized treatment strategies for patients with lung adenocarcinoma treated with EGFR-targeted therapies.

Few genome-wide association studies have examined genetic variants associated with hepatocellular carcinoma (HCC) risk in individuals seronegative for HBsAg and anti-HCV, and the long-term impact of these variants remains uncertain. This multi-stage study analyzed adults >30 years old who were seronegative for HBsAg and anti-HCV. In the genome-wide association study discovery phase, 765 HCC cases and 9,949 controls were analyzed for 308,693 SNPs, with significant SNPs confirmed in community-based (171 HCC cases, 684 controls) and hospital-based (470 HCC cases, 5,460 controls) validation sets. A cohort of 67,909 participants, followed from 2012 to 2021, was used to evaluate the long-term HCC risk associated with these variants. Ten SNPs in PNPLA3/SAMM50 were significantly associated with HCC risk (p <1.62 × 10-7) and were in high linkage disequilibrium. Three SNPs (rs738409, rs2281135, rs2235776) were replicated and demonstrated strong associations with HCC, independent of steatosis. Over 267,238 person-years of follow-up, 32 new HCC cases occurred, with elevated risks observed in individuals homozygous for the risk genotypes: GG (rs738409), AA (rs2281135), and TT (rs2235776). The adjusted hazard ratios (95% CI) were 3.37 (1.32-8.63), 2.80 (1.06-7.37), and 2.64 (0.91-7.66), respectively. In allelic models, carriers of the risk allele had higher HCC risk, with adjusted hazard ratios (95% CI) of 1.88 (1.14-3.10) for rs738409, 1.68 (1.02-2.78) for rs2281135, and 1.61 (0.98-2.67) for rs2235776. This study identified PNPLA3/SAMM50 variants significantly associated with long-term HCC risk in individuals without viral hepatitis. These findings highlight their potential utility as biomarkers for HCC risk stratification and underscore the need for further research into underlying mechanisms. Variants in the PNPLA3/SAMM50 locus were significantly associated with hepatocellular carcinoma (HCC) risk in individuals seronegative for HBsAg and anti-HCV. The stepwise increase in HCC risk with higher numbers of risk alleles suggests their potential utility as biomarkers to identify high-risk individuals without a history of chronic hepatitis B or C virus infection. These findings provide a foundation for genetic risk stratification and precision prevention strategies in populations where non-viral etiologies of HCC are becoming increasingly important.